Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.93 | 0.93 | 0.00 |
Shares | 99.07 | 99.07 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.08 | 15.54 |
Price to Book | 2.93 | 2.51 |
Price to Sales | 2.18 | 1.73 |
Price to Cash Flow | 12.43 | 10.69 |
Dividend Yield | 2.04 | 2.48 |
5 Years Earnings Growth | 9.18 | 9.37 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 19.37 | 20.69 |
Healthcare | 17.89 | 15.33 |
Industrials | 17.85 | 11.81 |
Technology | 11.53 | 12.68 |
Consumer Cyclical | 10.99 | 6.76 |
Communication Services | 7.67 | 5.51 |
Energy | 6.91 | 7.70 |
Basic Materials | 3.76 | 3.66 |
Real Estate | 3.25 | 3.60 |
Consumer Defensive | 0.77 | 8.46 |
Number of long holdings: 49
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPMorgan | US46625H1005 | 4.17 | 241.17 | -0.81% | |
Parker-Hannifin | US7010941042 | 4.13 | 643.81 | -1.17% | |
Meta Platforms | US30303M1027 | 3.67 | 599.81 | -0.59% | |
AbbVie | US00287Y1091 | 3.42 | 178.01 | -0.66% | |
Fiserv | US3377381088 | 3.39 | 207.95 | -1.11% | |
Goldman Sachs | US38141G1040 | 3.33 | 576.18 | -0.87% | |
Honeywell | US4385161066 | 3.27 | 229.51 | -1.01% | |
Abbott Labs | US0028241000 | 2.69 | 114.99 | -0.24% | |
Exxon Mobil | US30231G1022 | 2.60 | 106.48 | -0.01% | |
Eaton | IE00B8KQN827 | 2.51 | 334.63 | -1.63% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Homestead Growth | 398.18M | 33.10 | 10.17 | 15.80 | ||
Homestead Small Company Stock | 239.2M | 17.03 | 6.15 | 7.04 | ||
Homestead Stock Index | 265.4M | 20.48 | 8.58 | 12.41 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review